OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Results of a real-world study on vortioxetine in patients with major depressive disorder in South East Asia (REVIDA)
Cheuk Ngen Chin, Azhar Md. Zain, Solaphat Hemrungrojn, et al.
Current Medical Research and Opinion (2018) Vol. 34, Iss. 11, pp. 1975-1984
Closed Access | Times Cited: 20
Cheuk Ngen Chin, Azhar Md. Zain, Solaphat Hemrungrojn, et al.
Current Medical Research and Opinion (2018) Vol. 34, Iss. 11, pp. 1975-1984
Closed Access | Times Cited: 20
Showing 20 citing articles:
Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study
Gregory W. Mattingly, Hongye Ren, Michael Cronquist Christensen, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 27
Gregory W. Mattingly, Hongye Ren, Michael Cronquist Christensen, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 27
Randomized, double‐blind, placebo‐controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder
Takeshi Inoue, Kiyofumi Sasai, T Kitagawa, et al.
Psychiatry and Clinical Neurosciences (2019) Vol. 74, Iss. 2, pp. 140-148
Open Access | Times Cited: 36
Takeshi Inoue, Kiyofumi Sasai, T Kitagawa, et al.
Psychiatry and Clinical Neurosciences (2019) Vol. 74, Iss. 2, pp. 140-148
Open Access | Times Cited: 36
Effectiveness and Safety of Vortioxetine for the Treatment of Major Depressive Disorder in the Real World: A Systematic Review and Meta-Analysis
Zejun Li, Shouhuan Liu, Qiuxia Wu, et al.
The International Journal of Neuropsychopharmacology (2023) Vol. 26, Iss. 6, pp. 373-384
Open Access | Times Cited: 12
Zejun Li, Shouhuan Liu, Qiuxia Wu, et al.
The International Journal of Neuropsychopharmacology (2023) Vol. 26, Iss. 6, pp. 373-384
Open Access | Times Cited: 12
Effectiveness of vortioxetine in patients with major depressive disorder and comorbid Alzheimer’s disease in routine clinical practice: An analysis of a post-marketing surveillance study in South Korea
Eduardo Cumbo, Michael Adair, Daniel Oudin Åström, et al.
Frontiers in Aging Neuroscience (2023) Vol. 14
Open Access | Times Cited: 9
Eduardo Cumbo, Michael Adair, Daniel Oudin Åström, et al.
Frontiers in Aging Neuroscience (2023) Vol. 14
Open Access | Times Cited: 9
A Taiwanese study on real-world evidence with vortioxetine in patients with major depression in Asia (TREVIDA)
Yen Kuang Yang, Cheng-Sheng Chen, Chia-Fen Tsai, et al.
Current Medical Research and Opinion (2021) Vol. 37, Iss. 12, pp. 2163-2173
Closed Access | Times Cited: 14
Yen Kuang Yang, Cheng-Sheng Chen, Chia-Fen Tsai, et al.
Current Medical Research and Opinion (2021) Vol. 37, Iss. 12, pp. 2163-2173
Closed Access | Times Cited: 14
Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice in Italy: Results from the RELIEVE Study
Sergio De Filippis, Anna Pugliese, Michael Cronquist Christensen, et al.
Neuropsychiatric Disease and Treatment (2022) Vol. Volume 18, pp. 1665-1677
Open Access | Times Cited: 9
Sergio De Filippis, Anna Pugliese, Michael Cronquist Christensen, et al.
Neuropsychiatric Disease and Treatment (2022) Vol. Volume 18, pp. 1665-1677
Open Access | Times Cited: 9
Safety and effectiveness of vortioxetine for major depressive disorder: Real-world evidence from a population-based study in South Korea
Seok Woo Moon, Jee Wook Kim, Do Hoon Kim, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 4
Seok Woo Moon, Jee Wook Kim, Do Hoon Kim, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 4
Efficacy of vortioxetine versus desvenlafaxine in the treatment of functional impairment in patients with major depressive disorder: Results from the multinational VIVRE study
Michael Cronquist Christensen, Iría Grande, Andreas Rieckmann, et al.
CNS Spectrums (2024), pp. 1-10
Open Access | Times Cited: 1
Michael Cronquist Christensen, Iría Grande, Andreas Rieckmann, et al.
CNS Spectrums (2024), pp. 1-10
Open Access | Times Cited: 1
A comparison of real-world effectiveness of vortioxetine along the treatment algorithm for major depressive disorder
Rohini Bose, Syed Usman Hamdani, Faiza Aslam, et al.
Current Medical Research and Opinion (2022) Vol. 38, Iss. 5, pp. 661-671
Closed Access | Times Cited: 5
Rohini Bose, Syed Usman Hamdani, Faiza Aslam, et al.
Current Medical Research and Opinion (2022) Vol. 38, Iss. 5, pp. 661-671
Closed Access | Times Cited: 5
Relationship between work functioning and self-reported cognitive complaints in patients with major depressive disorder treated with desvenlafaxine
Esther Alonso-Prieto, Cristina Rubino, Megan Lucey, et al.
Psychiatry Research (2018) Vol. 272, pp. 144-148
Closed Access | Times Cited: 7
Esther Alonso-Prieto, Cristina Rubino, Megan Lucey, et al.
Psychiatry Research (2018) Vol. 272, pp. 144-148
Closed Access | Times Cited: 7
A Comparative Efficacy of Antidepressants in the Treatment of Major Depressive Disorder: A Systematic Review and Meta-Analysis
Sarah Naher
Journal of Sociology Psychology & Religious Studies (2023) Vol. 5, Iss. 2, pp. 40-69
Open Access | Times Cited: 2
Sarah Naher
Journal of Sociology Psychology & Religious Studies (2023) Vol. 5, Iss. 2, pp. 40-69
Open Access | Times Cited: 2
A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment
Ignacio Basurte-Villamor, Pablo Vega, Carlos Roncero, et al.
Neuropsychiatric Disease and Treatment (2022) Vol. Volume 18, pp. 965-976
Open Access | Times Cited: 4
Ignacio Basurte-Villamor, Pablo Vega, Carlos Roncero, et al.
Neuropsychiatric Disease and Treatment (2022) Vol. Volume 18, pp. 965-976
Open Access | Times Cited: 4
Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice: French Cohort Results from the Global RELIEVE Study
Mircea Polosan, Marc Rabbani, Michael Cronquist Christensen, et al.
Neuropsychiatric Disease and Treatment (2022) Vol. Volume 18, pp. 1963-1974
Open Access | Times Cited: 4
Mircea Polosan, Marc Rabbani, Michael Cronquist Christensen, et al.
Neuropsychiatric Disease and Treatment (2022) Vol. Volume 18, pp. 1963-1974
Open Access | Times Cited: 4
Effectiveness of 8-week TReatment with vortioxetine on depressive symptoms in major depressive disorder patients with comorbid generalized anxiety disorder in UAE (TRUE)
Bassem Badr, Hana Al Gailani, Samia Alkhoori, et al.
Annals of General Psychiatry (2024) Vol. 23, Iss. 1
Open Access
Bassem Badr, Hana Al Gailani, Samia Alkhoori, et al.
Annals of General Psychiatry (2024) Vol. 23, Iss. 1
Open Access
Vortioxetine in the Treatment of Major Depressive Disorder Among Working Patients in Routine Clinical Practice: An Analysis of a Post-Marketing Surveillance Study in South Korea
Seok Woo Moon, Jee Wook Kim, Do Hoon Kim, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 2299-2311
Open Access
Seok Woo Moon, Jee Wook Kim, Do Hoon Kim, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 2299-2311
Open Access
A Real-life Study of Brexpiprazole as an Adjunctive Treatment for Major Depressive Disorder in Asian Patients in Singapore (BADA)
Yee Ming Mok, Pei Lin Lynnette Tan, Rohini Bose, et al.
Clinical Psychopharmacology and Neuroscience (2024) Vol. 22, Iss. 3, pp. 531-536
Open Access
Yee Ming Mok, Pei Lin Lynnette Tan, Rohini Bose, et al.
Clinical Psychopharmacology and Neuroscience (2024) Vol. 22, Iss. 3, pp. 531-536
Open Access
The resolution of the Expert Council on the Diagnosis, Treatment, and Prevention of Symptoms of Depression in Outpatients with New Coronavirus Infection
О. М. Драпкина, Olga Grigorova, O. N. Dzhioeva, et al.
V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY (2022) Vol. 56, Iss. 4, pp. 112-123
Open Access | Times Cited: 1
О. М. Драпкина, Olga Grigorova, O. N. Dzhioeva, et al.
V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY (2022) Vol. 56, Iss. 4, pp. 112-123
Open Access | Times Cited: 1
A Comparative Efficacy of Antidepressants in the Treatment of Major Depressive Disorder: A Systematic Review and Meta-Analysis
Sarah Alnaher, Moayad Alramahi, Abdul Karim Arida, et al.
Cognizance Journal of Multidisciplinary Studies (2023) Vol. 3, Iss. 10, pp. 520-549
Open Access
Sarah Alnaher, Moayad Alramahi, Abdul Karim Arida, et al.
Cognizance Journal of Multidisciplinary Studies (2023) Vol. 3, Iss. 10, pp. 520-549
Open Access
A 6-Month Open-Label Study of Vortioxetine among Cancer Patients with Major Depressive Disorder (MDD)
Ng Chong Guan, Aya Ahmed Abousheishaa, Sue Yin Low, et al.
Asian Pacific Journal of Cancer Prevention (2023) Vol. 24, Iss. 8, pp. 2583-2591
Open Access
Ng Chong Guan, Aya Ahmed Abousheishaa, Sue Yin Low, et al.
Asian Pacific Journal of Cancer Prevention (2023) Vol. 24, Iss. 8, pp. 2583-2591
Open Access
The effectiveness of vortioxetine in patients with depression in real clinical practice
Н. Н. Петрова
V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY (2022) Vol. 56, Iss. 3, pp. 113-118
Open Access
Н. Н. Петрова
V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY (2022) Vol. 56, Iss. 3, pp. 113-118
Open Access
